9 Tips for Navigating the Inevitable Unexpected
Michael McKinney
MARCH 12, 2024
If sophisticated investors are involved — as often happens in biotech — the plan is undoubtedly subjected to intensive due diligence. The number of factors one would need to have considered, accounted for, and correctly predicted to have a “perfect plan” is comparable to the number of stars in the sky.
Let's personalize your content